FILE:DVA/DVA-8K-20080220141907.txt.gz
EVENTS:	Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers	Financial Statements and Exhibits
TEXT:
ITEM: Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
ITEM: Financial Statements and Exhibits
 
 
 
 
 
 
 
 
 
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
 
 
 
 
 
 
On February 13, 2008, the Board of Directors of DaVita Inc. (the "Company") approved the appointment of Richard K. Whitney as the Company's Chief Financial Officer, effective March 1, 2008. Mr. Whitney will be working in this capacity with the Company on a part-time basis that is expected to continue for one to two years. As described in the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 7, 2007, effective November 30, 2007, Mark G. Harrison stepped down as Chief Financial Officer of the Company and James Hilger, the Company's Vice President and Controller, became the Company's acting Chief Financial Officer. Effective March 1, 2008, Mr. Hilger will relinquish his duties as acting Chief Financial Officer of the Company.
Mr. Whitney rejoined the Company on February 13, 2008 as an employee prior to the effectiveness of his appointment as the Company's Chief Financial Officer. Since December 2005, Mr. Whitney, age 40, was the founder and serves as a managing member of Whitney Capital, LLC, a private equity investment firm which invests primarily in healthcare services and products companies. Since December 2006, Mr. Whitney has served as a venture partner of New Enterprise Associates, a private equity firm. From February 2005 to January 2006, Mr. Whitney served as Chairman of the Board of Specialty Laboratories, Inc., a reference laboratory services company, and as a director of Specialty Laboratories, Inc. from September 2004 to January 2006. From February 2000 to February 2004, Mr. Whitney served as the Chief Financial Officer of the Company. Mr. Whitney is a Certified Public Accountant and holds a B.S. in Business Administration from Pennsylvania State University and an M.B.A. from Harvard Business School.
There are no family relationships between Mr. Whitney and any other director or executive officer of the Company, or with any person selected to become an officer or a director of the Company. Except as set forth below, the Company has had no transactions since the beginning of its last fiscal year, and has no transactions proposed, in which Mr. Whitney, or any member of his immediate family, has a direct or indirect material interest. During the fiscal year ended December 31, 2007, the Company paid Whitney Capital LLC a private equity investment firm where Mr. Whitney was the founder and serves as a managing member, an aggregate of approximately $544,000 in fees for consulting services. From January 1, 2008 to February 13, 2008, the Company paid Whitney Capital LLC an aggregate of approximately $88,750 in fees for consulting services.
,
 
(d) Exhibits.
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: February 20, 2008
 
 

Exhibit 99.1
 
EL SEGUNDO, CA, February 13, 2008, DaVita Inc. (NYSE: DVA), today announced that Richard K. Whitney has rejoined and will be appointed Chief Financial Officer effective March, 1, 2008. Rich will be working with DaVita in a part-time role that is expected to go on for 1 to 2 years.
Kent Thiry, Chief Executive Officer, commented, "We are glad to have Rich once again join the DaVita team. Rich has been working with us the past few years on a consulting basis since his departure in 2004. He is a natural fit in our organization and brings a wealth of financial and industry experience to the role."
Currently, Rich is founder and Managing Member of Whitney Capital, LLC, a private equity investment firm which invests primarily in healthcare services and products companies. Mr. Whitney also serves as a Venture Partner with New Enterprise Associates. From 2005 to 2006, Mr. Whitney was Executive Chairman of Specialty Laboratories (previously NYSE: SP) where he led the turnaround and sale of the Company for approximately $300 million. From 2000 to 2004, Mr. Whitney served as Chief Financial Officer of DaVita Inc.
DaVita Inc. is a leading provider of kidney care in the United States, providing dialysis services and education for patients with chronic kidney failure and end stage renal disease. DaVita manages over 1,300 outpatient facilities and acute units in over 700 hospitals located in 43 states and the District of Columbia, serving more than 103,000 patients.


